Cash flow Concord Biotech Limited

Stocks

CONCORDBIO

INE338H01029

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:07 17/07/2026 pm IST			5-day change	1st Jan Change
1,342.80 ^INR	-0.24%		+2.92%	-0.21%

20/06	Fsge Renewable Power Private Limited announced that it expects to receive INR 63 million in funding from Concord Biotech Limited	CI
12/06	Brazilian Regulator Completes Inspection of Concord Biotech's Limbasi Facility	MT

4958666a2d6a77e1760.EkRsWCqeKLR4W68waraoF79cYCl2jSW34310HBngjl0.US1ZGmPKYNE7K8MGAMflT9RkGFoMy3HejRwXdWCQ4jJmD1wTYdBb9kEh2A

Published financial data: CONCORD BIOTECH LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	712.93Cr	853.17Cr	1.02TCr	1.2TCr	1.05TCr
Total Revenues	712.93Cr	853.17Cr	1.02TCr	1.2TCr	1.05TCr
Cost of Goods Sold, Total	171.92Cr	192.08Cr	244.78Cr	431.73Cr	378.32Cr
Gross Profit	541.01Cr	661.09Cr	772.16Cr	768.36Cr	676.57Cr
Selling General & Admin Expenses, Total	96Cr	110.29Cr	123.07Cr	138.93Cr	176.9Cr
Provision for Bad Debts	-	-	-	-	-
Depreciation & Amortization - (IS)	50Cr	54Cr	54Cr	54Cr	74Cr
Other Operating Expenses	166.25Cr	197.34Cr	208.73Cr	112.22Cr	120.91Cr
Other Operating Expenses, Total	311.99Cr	361.66Cr	385.39Cr	305.53Cr	372.27Cr
Operating Income	229.02Cr	299.42Cr	386.76Cr	462.83Cr	304.3Cr
Interest Expense, Total	-5.48Cr	-4.51Cr	-2.55Cr	-52.93L	-28.32L
Interest And Investment Income	4.79Cr	4.44Cr	3.04Cr	1.71Cr	2.46Cr
Net Interest Expenses	-69.7L	-7L	48.92L	1.18Cr	2.18Cr
Income (Loss) On Equity Invest.	-3.64Cr	1.96Cr	3.37Cr	-1.32Cr	2.91Cr
Currency Exchange Gains (Loss)	6.36Cr	10Cr	6.48Cr	8.2Cr	16Cr
Other Non Operating Income (Expenses)	97.3L	6.2Cr	1.24Cr	1.62Cr	1.38Cr
EBT, Excl. Unusual Items	232.02Cr	317.74Cr	398.35Cr	472.51Cr	326.78Cr
Gain (Loss) On Sale Of Investments	5.23Cr	3.72Cr	14Cr	22Cr	21Cr
Gain (Loss) On Sale Of Assets	-3L	-9L	1L	-22.47L	1L
Insurance Settlements	30.3L	65.1L	14.14L	9T	-
Other Unusual Items	-	-	-	-	-3.28Cr
EBT, Incl. Unusual Items	237.52Cr	322.01Cr	412.56Cr	494.55Cr	344.65Cr
Income Tax Expense	63Cr	82Cr	104.46Cr	122.91Cr	85Cr
Earnings From Continuing Operations	174.93Cr	240.09Cr	308.1Cr	371.64Cr	259.23Cr
Net Income to Company	174.93Cr	240.09Cr	308.1Cr	371.64Cr	259.23Cr
Minority Interest	-	-	-	-	1.68Cr
Net Income - (IS)	174.93Cr	240.09Cr	308.1Cr	371.64Cr	260.91Cr
Net Income to Common Incl Extra Items	174.93Cr	240.09Cr	308.1Cr	371.64Cr	260.91Cr
Net Income to Common Excl. Extra Items	174.93Cr	240.09Cr	308.1Cr	371.64Cr	260.91Cr
Per Share Items
Net EPS - Basic	16.72	22.95	29.45	35.52	24.94
Basic EPS - Continuing Operations	16.72	22.95	29.45	35.52	24.94
Basic Weighted Average Shares Outstanding	10Cr	10Cr	10Cr	10Cr	10Cr
Net EPS - Diluted	16.72	22.95	29.45	35.52	24.94
Diluted EPS - Continuing Operations	16.72	22.95	29.45	35.52	24.94
Diluted Weighted Average Shares Outstanding	10Cr	10Cr	10Cr	10Cr	10Cr
Normalized Basic EPS	13.86	18.98	23.8	28.23	19.68
Normalized Diluted EPS	13.86	18.98	23.8	28.23	19.68
Dividend Per Share	5.12	6.83	8.75	10.7	7.55
Payout Ratio	40.31	22.31	23.19	24.63	42.9
Supplemental Items
EBITDA	277.82Cr	352.21Cr	438.62Cr	515.44Cr	376.88Cr
EBITA	232.26Cr	302.66Cr	387.05Cr	463.14Cr	304.65Cr
EBIT	229.02Cr	299.42Cr	386.76Cr	462.83Cr	304.3Cr
EBITDAR	277.82Cr	352.22Cr	438.64Cr	-	-
Total Revenues (As Reported)	736.35Cr	888.48Cr	1.05TCr	1.24TCr	1.11TCr
Effective Tax Rate - (Ratio)	26.35	25.44	25.32	24.85	24.78
Total Current Taxes	58Cr	80Cr	100Cr	118.96Cr	86Cr
Total Deferred Taxes	3.7Cr	2.38Cr	4.63Cr	3.95Cr	-87.28L
Normalized Net Income	145.01Cr	198.59Cr	248.97Cr	295.32Cr	205.92Cr
Interest on Long-Term Debt	31.4L	18.19L	2.28Cr	47.55L	28.2L
Non-Cash Pension Expense	2L	6L	4L	3L	3.42Cr
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	-	33Cr	23Cr	27Cr	29Cr
Net Rental Expense, Total	20T	71T	2L	-	-
Imputed Operating Lease Interest Expense	11.56T	54.48T	2L	-	-
Imputed Operating Lease Depreciation	8.44T	16.52T	2.2T	-	-
Maintenance & Repair Expenses, Total	7.91Cr	12Cr	16Cr	14Cr	16Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	66.7L	3.5Cr	15Cr	90.45L	12Cr
Short Term Investments	87Cr	31Cr	23Cr	18Cr	18Cr
Trading Asset Securities, Total	73Cr	136.93Cr	243.7Cr	316.54Cr	402.06Cr
Total Cash And Short Term Investments	161.39Cr	171.01Cr	281.67Cr	335.44Cr	431.88Cr
Accounts Receivable, Total	232.17Cr	273.76Cr	349.61Cr	521.65Cr	460.2Cr
Other Receivables	27Cr	22Cr	16Cr	21Cr	10Cr
Total Receivables	259.45Cr	295.55Cr	365.61Cr	542.7Cr	470.35Cr
Inventory	195.12Cr	212.31Cr	207.95Cr	239.67Cr	326.36Cr
Prepaid Expenses	4.76Cr	5.52Cr	7.33Cr	7.39Cr	7.56Cr
Other Current Assets, Total	12Cr	43Cr	34Cr	10Cr	14Cr
Total Current Assets	632.67Cr	727.7Cr	896.23Cr	1.14TCr	1.25TCr
Gross Property Plant And Equipment	781.4Cr	952.79Cr	1.02TCr	1.13TCr	1.23TCr
Accumulated Depreciation	-137.85Cr	-187.31Cr	-238.46Cr	-288.67Cr	-360.11Cr
Net Property Plant And Equipment	643.56Cr	765.48Cr	786.48Cr	844.22Cr	866.06Cr
Long-term Investments	25.6L	12.46L	2.07Cr	23Cr	89Cr
Goodwill	-	-	-	-	39.63L
Other Intangibles, Total	3.58Cr	19.77L	31.97L	1.12Cr	1.42Cr
Deferred Tax Assets Long-Term	-	-	-	-	2.94Cr
Other Long-Term Assets, Total	33Cr	20Cr	16Cr	31Cr	25Cr
Total Assets	1.31TCr	1.51TCr	1.7TCr	2.03TCr	2.23TCr
Liabilities
Accounts Payable, Total	83Cr	94Cr	94Cr	113.04Cr	101.91Cr
Accrued Expenses, Total	13Cr	15Cr	17Cr	19Cr	23Cr
Short-term Borrowings	4.34Cr	-	-	38.11L	-
Current Portion of Long-Term Debt	25Cr	25Cr	6.23Cr	-	-
Current Portion of Leases	1.6Cr	14.69L	1.62Cr	1.96Cr	88.22L
Current Income Taxes Payable	-	9Cr	5.49Cr	10Cr	92T
Unearned Revenue Current, Total	3.27Cr	1.31Cr	-	-	-
Other Current Liabilities	25Cr	48Cr	18Cr	39Cr	43Cr
Total Current Liabilities	155.17Cr	191.84Cr	142.16Cr	184.06Cr	169.08Cr
Long-Term Debt	31Cr	6.24Cr	-	-	-
Long-Term Leases	31.1L	16.38L	1.89Cr	62.98L	1.43Cr
Deferred Tax Liability Non Current	21Cr	23Cr	28Cr	34Cr	45Cr
Other Non Current Liabilities	1.87Cr	2.3Cr	1.96Cr	2.82Cr	3.72Cr
Total Liabilities	209.57Cr	223.98Cr	174.06Cr	221.53Cr	219.59Cr
Common Stock, Total	9.51Cr	10Cr	10Cr	10Cr	10Cr
Additional Paid In Capital	83Cr	82Cr	82Cr	82Cr	82Cr
Retained Earnings	1.01TCr	1.2TCr	1.43TCr	1.72TCr	1.93TCr
Comprehensive Income and Other	-	-	-	-	-40.09L
Total Common Equity	1.1TCr	1.29TCr	1.53TCr	1.81TCr	2.02TCr
Minority Interest	-	-	-	-	-1.92Cr
Total Equity	1.1TCr	1.29TCr	1.53TCr	1.81TCr	2.02TCr
Total Liabilities And Equity	1.31TCr	1.51TCr	1.7TCr	2.03TCr	2.23TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10Cr	10Cr	10Cr	10Cr	10Cr
ECS Total Common Shares Outstanding	10Cr	10Cr	10Cr	10Cr	10Cr
Book Value / Share	105.45	123.31	145.93	173.27	192.81
Tangible Book Value	1.1TCr	1.29TCr	1.53TCr	1.81TCr	2.02TCr
Tangible Book Value Per Share	105.11	123.29	145.9	173.17	192.63
Total Debt	62Cr	32Cr	9.74Cr	2.97Cr	2.32Cr
Net Debt	-99Cr	-139.46Cr	-271.93Cr	-332.47Cr	-429.57Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	93.5L	57.67L	42.7L	58.03L	4.58Cr
Debt Equivalent Oper. Leases	2L	6L	16L	-	-
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-1.92Cr
Equity Method Investments, Total	-	-	2.06Cr	73.65L	3.65Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	81Cr	80Cr	63Cr	80Cr	95Cr
Inventories - Work In Process, Total	90Cr	113.2Cr	123.48Cr	133.83Cr	194.23Cr
Inventories - Finished Goods, Total	22Cr	15Cr	17Cr	21Cr	32Cr
Inventories - Others	1.94Cr	3.89Cr	4.57Cr	4.82Cr	5.39Cr
Land - (BS)	55Cr	55Cr	55Cr	63Cr	63Cr
Buildings, Total	222.63Cr	246.29Cr	257.57Cr	355.33Cr	373.17Cr
Machinery, Total	428.54Cr	478.83Cr	497.91Cr	662.16Cr	709.66Cr
Full Time Employees	1.18T	-	1.38T	1.57T	1.62T
Accumulated Allowance for Doubtful Accounts (Supple)	78.1L	87.3L	1.39Cr	3.18Cr	5.93Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	174.93Cr	240.09Cr	308.1Cr	371.64Cr	260.91Cr
Depreciation & Amortization - CF	47Cr	51Cr	53Cr	54Cr	74Cr
Amortization of Goodwill and Intangible Assets - (CF)	3.24Cr	3.24Cr	28.99L	30.1L	35.04L
Depreciation & Amortization, Total	50Cr	54Cr	54Cr	54Cr	74Cr
Amortization of Deferred Charges, Total - (CF)	15.5L	13.89L	5L	1L	10T
(Gain) Loss From Sale Of Asset	3L	9L	-1L	22.47L	-1L
(Gain) Loss on Sale of Investments - (CF)	-5.23Cr	-3.72Cr	-14Cr	-22Cr	-21Cr
(Income) Loss On Equity Investments - (CF)	3.64Cr	-1.96Cr	-3.37Cr	1.32Cr	-2.91Cr
Provision and Write-off of Bad Debts	-34.6L	9L	66.94L	1.78Cr	2.76Cr
Other Operating Activities, Total	6.45Cr	12Cr	1.73Cr	8.19Cr	-33Cr
Change In Accounts Receivable	-53Cr	-43Cr	-79Cr	-170.79Cr	70Cr
Change In Inventories	-42Cr	-17Cr	4.36Cr	-32Cr	-87Cr
Change In Accounts Payable	37Cr	9.88Cr	-11Cr	22Cr	-8.52Cr
Change in Other Net Operating Assets	36Cr	-1.84Cr	4.41Cr	9.65Cr	11Cr
Cash from Operations	207.48Cr	248.3Cr	265.47Cr	244.52Cr	266.88Cr
Capital Expenditure	-155.5Cr	-145.08Cr	-86Cr	-111.17Cr	-95Cr
Sale of Property, Plant, and Equipment	6L	3L	17.51L	19.9L	10.03L
Investment in Marketable and Equity Securities, Total	40Cr	-18Cr	-72Cr	-52Cr	-50Cr
Other Investing Activities, Total	4.14Cr	5.58Cr	2.77Cr	2.99Cr	2.4Cr
Cash from Investing	-111.79Cr	-157.95Cr	-154.61Cr	-159.99Cr	-142.72Cr
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-76.1L	-	-	-	-38.11L
Long-Term Debt Repaid, Total	-27Cr	-27Cr	-27Cr	-6.75Cr	-27.26L
Total Debt Repaid	-27Cr	-27Cr	-27Cr	-6.75Cr	-65.37L
Common Dividends Paid	-71Cr	-54Cr	-71Cr	-92Cr	-111.94Cr
Common & Preferred Stock Dividends Paid	-71Cr	-54Cr	-71Cr	-92Cr	-111.94Cr
Other Financing Activities, Total	-2.23Cr	-54.07L	-1.26Cr	-48.35L	-28.32L
Cash from Financing	-100.16Cr	-81Cr	-99Cr	-99Cr	-112.88Cr
Miscellaneous Cash Flow Adjustments	-	-6.63Cr	-	-	-
Net Change in Cash	-4.48Cr	2.83Cr	12Cr	-14Cr	11Cr
Supplemental Items
Cash Interest Paid	5.32Cr	3.78Cr	2.65Cr	63.32L	28.32L
Cash Income Tax Paid (Refund)	61Cr	70Cr	103.35Cr	109.42Cr	100.41Cr
Levered Free Cash Flow	19Cr	50Cr	117.77Cr	94Cr	137.36Cr
Unlevered Free Cash Flow	22Cr	53Cr	119.36Cr	95Cr	137.54Cr
Change In Net Working Capital	15Cr	43Cr	90Cr	137.82Cr	32Cr
Net Debt Issued / Repaid	-27Cr	-27Cr	-27Cr	-6.75Cr	-65.37L

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	11.47	13.24	15.04	15.49	8.91
Return on Total Capital	12.7	15.05	16.92	17.26	9.92
Return On Equity %	16.64	20.06	21.88	22.26	13.54
Return on Common Equity	16.64	20.06	21.88	22.26	13.63
Margin Analysis
Gross Profit Margin %	75.89	77.49	75.93	64.03	64.14
SG&A Margin	13.42	12.93	12.1	11.58	16.77
EBITDA Margin %	38.97	41.28	43.13	42.95	35.73
EBITA Margin %	32.58	35.48	38.06	38.59	28.88
EBIT Margin %	32.12	35.1	38.03	38.57	28.85
Income From Continuing Operations Margin %	24.54	28.14	30.3	30.97	24.57
Net Income Margin %	24.54	28.14	30.3	30.97	24.73
Net Avail. For Common Margin %	24.54	28.14	30.3	30.97	24.73
Normalized Net Income Margin	20.34	23.28	24.48	24.61	19.52
Levered Free Cash Flow Margin	2.65	5.9	11.58	7.86	13.02
Unlevered Free Cash Flow Margin	3.13	6.23	11.74	7.89	13.04
Asset Turnover
Asset Turnover	0.57	0.6	0.63	0.64	0.49
Fixed Assets Turnover	1.19	1.21	1.31	1.47	1.23
Receivables Turnover (Average Receivables)	3.48	3.37	3.26	2.75	2.15
Inventory Turnover (Average Inventory)	0.99	0.94	1.16	1.93	1.34
Short Term Liquidity
Current Ratio	4.08	3.79	6.3	6.17	7.39
Quick Ratio	2.71	2.43	4.55	4.77	5.34
Operating Cash Flow to Current Liabilities	1.34	1.29	1.87	1.33	1.58
Days Sales Outstanding (Average Receivables)	104.87	108.22	112.18	132.49	169.86
Days Outstanding Inventory (Average Inventory)	370.19	387.11	314.19	189.22	273.05
Average Days Payable Outstanding	110.74	154.27	143.28	81.7	84.36
Cash Conversion Cycle (Average Days)	364.33	341.06	283.09	240.01	358.55
Long Term Solvency
Total Debt/Equity	5.66	2.45	0.64	0.16	0.11
Total Debt / Total Capital	5.36	2.39	0.63	0.16	0.11
LT Debt/Equity	2.86	0.5	0.12	0.03	0.07
Long-Term Debt / Total Capital	2.71	0.48	0.12	0.03	0.07
Total Liabilities / Total Assets	15.96	14.79	10.23	10.89	9.83
EBIT / Interest Expense	41.76	66.39	151.56	874.43	1.07T
EBITDA / Interest Expense	50.86	78.34	172.54	977.13	1.34T
(EBITDA - Capex) / Interest Expense	22.5	46.17	138.96	767.09	1T
Total Debt / EBITDA	0.22	0.09	0.02	0.01	0.01
Net Debt / EBITDA	-0.35	-0.39	-0.62	-0.64	-1.13
Total Debt / (EBITDA - Capex)	0.51	0.15	0.03	0.01	0.01
Net Debt / (EBITDA - Capex)	-0.8	-0.67	-0.77	-0.82	-1.51
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	15.56	19.67	19.2	18.01	-12.1
Gross Profit, 1 Yr. Growth %	8.2	22.19	16.8	15.16	-11.95
EBITDA, 1 Yr. Growth %	-15.48	26.78	24.38	17.52	-26.88
EBITA, 1 Yr. Growth %	-23.97	30.31	27.7	19.66	-34.22
EBIT, 1 Yr. Growth %	-24.26	30.74	28.98	19.67	-34.25
Earnings From Cont. Operations, 1 Yr. Growth %	-25.53	37.25	28.33	20.62	-30.25
Net Income, 1 Yr. Growth %	-25.53	37.25	28.33	20.62	-29.8
Normalized Net Income, 1 Yr. Growth %	-24.11	36.94	25.36	18.62	-30.27
Diluted EPS Before Extra, 1 Yr. Growth %	-25.52	37.25	28.33	20.62	-29.8
Accounts Receivable, 1 Yr. Growth %	30.79	17.91	27.71	49.21	-11.78
Inventory, 1 Yr. Growth %	27.02	8.81	-2.05	15.25	36.17
Net Property, Plant and Equip., 1 Yr. Growth %	15.38	18.95	2.74	7.34	2.59
Total Assets, 1 Yr. Growth %	11.01	15.33	12.33	19.61	9.86
Tangible Book Value, 1 Yr. Growth %	10.74	17.29	18.34	18.69	11.24
Common Equity, 1 Yr. Growth %	10.39	16.93	18.34	18.74	11.27
Cash From Operations, 1 Yr. Growth %	24.37	19.29	7.91	-7.89	9.15
Capital Expenditures, 1 Yr. Growth %	-23.84	-6.7	-40.94	29.74	-14.41
Levered Free Cash Flow, 1 Yr. Growth %	-122.71	166.37	132.77	-19.91	45.63
Unlevered Free Cash Flow, 1 Yr. Growth %	-126.96	138.1	123.47	-20.7	45.31
Dividend Per Share, 1 Yr. Growth %	-24.05	33.4	28.11	22.29	-29.44
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.96	17.6	19.43	18.6	1.85
Gross Profit, 2 Yr. CAGR %	20.23	14.99	19.47	7.81	0.7
EBITDA, 2 Yr. CAGR %	13.93	3.51	25.65	20.9	-7.3
EBITA, 2 Yr. CAGR %	9.42	-0.46	29.09	23.61	-11.28
EBIT, 2 Yr. CAGR %	8.65	-0.49	29.95	24.24	-11.3
Earnings From Cont. Operations, 2 Yr. CAGR %	1.71	1.1	32.71	24.42	-8.27
Net Income, 2 Yr. CAGR %	1.71	1.1	32.71	24.42	-7.98
Normalized Net Income, 2 Yr. CAGR %	7.4	1.94	31.03	21.94	-9.06
Diluted EPS Before Extra, 2 Yr. CAGR %	1.7	1.11	32.71	24.42	-7.98
Accounts Receivable, 2 Yr. CAGR %	12.48	24.18	22.71	38.04	14.73
Inventory, 2 Yr. CAGR %	32.44	17.57	3.24	6.25	25.27
Net Property, Plant and Equip., 2 Yr. CAGR %	29.98	17.15	10.55	5.02	4.94
Total Assets, 2 Yr. CAGR %	18.14	13.15	13.82	15.92	14.63
Tangible Book Value, 2 Yr. CAGR %	19.49	13.97	17.81	18.51	14.91
Common Equity, 2 Yr. CAGR %	19.68	13.61	17.64	18.54	14.95
Cash From Operations, 2 Yr. CAGR %	15.75	22	12.93	-0.3	0.27
Capital Expenditures, 2 Yr. CAGR %	0.01	-15.7	-25.77	-12.46	5.38
Levered Free Cash Flow, 2 Yr. CAGR %	-	-22.23	149.69	36.54	8
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-19.88	131.27	33.12	7.34
Dividend Per Share, 2 Yr. CAGR %	11.56	0.66	30.73	25.16	-7.11
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	18.53	18.13	18.96	7.33
Gross Profit, 3 Yr. CAGR %	-	20.88	15.59	12.4	0.77
EBITDA, 3 Yr. CAGR %	-	18.06	10.09	22.88	2.24
EBITA, 3 Yr. CAGR %	-	15.98	8.21	25.87	0.17
EBIT, 3 Yr. CAGR %	-	15.57	8.55	26.43	0.49
Earnings From Cont. Operations, 3 Yr. CAGR %	-	12.39	9.47	28.55	2.59
Net Income, 3 Yr. CAGR %	-	12.39	9.47	28.55	2.81
Normalized Net Income, 3 Yr. CAGR %	-	16.46	9.22	26.75	1.21
Diluted EPS Before Extra, 3 Yr. CAGR %	-	12.39	9.47	28.55	2.81
Accounts Receivable, 3 Yr. CAGR %	-	14.26	25.35	30.98	18.9
Inventory, 3 Yr. CAGR %	-	24.05	10.62	7.1	15.41
Net Property, Plant and Equip., 3 Yr. CAGR %	-	26.19	12.14	9.47	4.2
Total Assets, 3 Yr. CAGR %	-	17.2	12.88	15.72	13.86
Tangible Book Value, 3 Yr. CAGR %	-	18.75	15.41	18.11	16.04
Common Equity, 3 Yr. CAGR %	-	18.76	15.17	18	16.07
Cash From Operations, 3 Yr. CAGR %	-	17.05	16.75	5.52	2.75
Capital Expenditures, 3 Yr. CAGR %	-	-2.28	-25.13	-10.58	-13.12
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	12.28	70.92	39.5
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	12.98	61.87	37.06
Dividend Per Share, 3 Yr. CAGR %	-	18.41	9.08	27.85	3.4
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	18.56	11.32
Gross Profit, 5 Yr. CAGR %	-	-	-	15.47	6.24
EBITDA, 5 Yr. CAGR %	-	-	-	19.22	2.77
EBITA, 5 Yr. CAGR %	-	-	-	19.01	-0.06
EBIT, 5 Yr. CAGR %	-	-	-	18.99	0.13
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	17.06	1.99
Net Income, 5 Yr. CAGR %	-	-	-	17.06	2.12
Normalized Net Income, 5 Yr. CAGR %	-	-	-	18.62	1.51
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	17.06	2.13
Accounts Receivable, 5 Yr. CAGR %	-	-	-	23.24	20.99
Inventory, 5 Yr. CAGR %	-	-	-	16.59	16.27
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	17.25	9.2
Total Assets, 5 Yr. CAGR %	-	-	-	16.68	13.57
Tangible Book Value, 5 Yr. CAGR %	-	-	-	18.66	15.21
Common Equity, 5 Yr. CAGR %	-	-	-	18.67	15.08
Cash From Operations, 5 Yr. CAGR %	-	-	-	9.57	9.85
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-6.49	-14.16
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	10.55
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	10.69
Dividend Per Share, 5 Yr. CAGR %	-	-	-	21.07	2.29